Ross A MD Jaffe

Ross A MD Jaffe has an estimated net worth of $4.02 Million. This is based on reported shares across multiple companies, which include INSULET CORP, PHASERX, INC., THERASENSE INC, GLAUKOS Corp, Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, MINERVA SURGICAL INC, NOVACEA INC, GENOMIC HEALTH INC, HELICOS BIOSCIENCES CORP, INTRALASE CORP, Alexza Pharmaceuticals Inc., and Flexion Therapeutics Inc.

2003 was Ross A MD Jaffe's most active year for acquiring shares with 2 total transactions. Ross A MD Jaffe's most active month to acquire stocks was the month of April. 2004 was Ross A MD Jaffe's most active year for disposing of shares, totalling 4 transactions. Ross A MD Jaffe's most active month to dispose stocks was the month of March. 2022 saw Ross A MD Jaffe paying a total of $119,998.72 for 49,792 shares, this is the most they've acquired in one year. In 2004 Ross A MD Jaffe cashed out on 44,379 shares for a total of $896,733.00, their largest year based on trade value.